Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 3;18(13):e202300104.
doi: 10.1002/cmdc.202300104. Epub 2023 May 4.

Functionalized Cyclopentenones with Low Electrophilic Character as Anticancer Agents

Affiliations

Functionalized Cyclopentenones with Low Electrophilic Character as Anticancer Agents

Késsia H S Andrade et al. ChemMedChem. .

Abstract

In this study were synthesized non-Michael acceptor cyclopentenones (CP) from biomass derivative furfural as anticancer agents. Cyclic enones, both from natural sources and synthetic analogues, have been described as cytotoxic agents. Most of these agents were unsuccessful in becoming valuable therapeutic agents due to toxicity problems derived from unselective critical biomacromolecule alkylation. This may be caused by Michael addition to the enone system. Ab initio studies revealed that 2,4-substituted CPs are less prone to Michael additions, and as such were tested three families of those derivatives. We prepare the new CPs from furfural through a tandem furan ring opening/Nazarov electrocyclization and further functionalization. Experimentally the 2,4-substituted CPs exhibited no reactivity towards sulphur nucleophiles, while maintaining cytotoxicity against HT-29, MCF-7, NCI-H460, HCT-116 and MDA-MB 231 cells lines. Moreover, the selected CP are non-toxic against healthy HEK 293T cell lines and present proper calculated drug-like properties.

Keywords: biomass; cancer; cyclopentenone; medicinal chemistry; sustainable chemistry.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J. W. W. Coebergh, H. Comber, D. Forman, F. Bray, Eur. J. Cancer 2013, 49, 1374-1403.
    1. S. Toden, H.-M. Tran, O. A. Tovar-Camargo, Y. Okugawa, A. Goel, Oncotarget 2016, 7, 16158-16171.
    1. S. Thota, D. A. Rodrigues, D. C. Crans, E. J. Barreiro, J. Med. Chem. 2018, 61, 5805-5821.
    1. M. A. Malik, O. A. Dar, P. Gull, M. Y. Wanibc, A. A. Hashmi, MedChemComm 2018, 9, 409-436.
    1. X. Zhang, K. P. Rakesh, C. S. Shantharam, H. M. Manukumar, A. M. Asiri, H. M. Marwani, H. Qin, Bioorg. Med. Chem. 2018, 26, 340-355.

Publication types

LinkOut - more resources